Precision Neuroscience
A medical device company developing a brain-computer interface to restore communication and movement.
Precision Neuroscience is a healthtech company based in New York City, US, founded in 2021. It has raised $250 million in disclosed funding. Its latest round was a Series D of $250 million in September 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $250M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| $250M | Series D | Pershing Square Inc., The Ackman Oxman Institute, Undisclosed leading life sciences investment fund | Duquesne Family Office +8 | Healthtech | 1 |
Led by Pershing Square Inc., The Ackman Oxman Institute, Undisclosed leading life sciences investment fund · with Duquesne Family Office, +8
Investors
Questions and answers
What does Precision Neuroscience do?
A medical device company developing a brain-computer interface to restore communication and movement.
How much has Precision Neuroscience raised?
Precision Neuroscience has raised $250 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Precision Neuroscience?
Investors in Precision Neuroscience include Pershing Square Inc., The Ackman Oxman Institute, Undisclosed leading life sciences investment fund, Duquesne Family Office, B Capital and 7 more.
When and where was Precision Neuroscience founded?
Precision Neuroscience was founded in 2021 and is based in New York City, US.
Timeline
Founded
Sources
- 1.The AlleyWatch Startup Daily Funding Report: 9/25/2026 — AlleyWatch, Sep 25, 2026